| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5615802 | The Journal of Heart and Lung Transplantation | 2017 | 27 Pages |
Abstract
Bone marrow mononuclear cell therapy for cardiomyopathy is feasible and safe in children. Left ventricular volumes were significantly reduced 6 months after stem cell injection compared with placebo, which may reflect reverse remodeling.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
E. Sian PhD, MRCPCH, Deborah MSc, Margaret BSC, Angus FRCA, Vivek MD, MRCPCH, Michael MD, FRCP, FRCPCH,